{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:02:01Z","timestamp":1790622121195,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":3167,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1038\/sj.jid.5700648","type":"journal-article","created":{"date-parts":[[2006,11,30]],"date-time":"2006-11-30T13:30:09Z","timestamp":1164893409000},"page":"802-807","source":"Crossref","is-referenced-by-count":65,"title":["Soluble FAS Ligand: A Discriminating Feature between Drug-Induced Skin Eruptions and Viral Exanthemas"],"prefix":"10.1016","volume":"127","author":[{"given":"Karoline","family":"Stur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz M.","family":"Karlhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Stingl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.jid.5700648_bb0010","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)64284-8","article-title":"Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome are induced by soluble Fas ligand","volume":"162","author":"Abe","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1038\/sj.jid.5700648_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens\u2013Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.jid.5700648_bb0020","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(97)11369-1","article-title":"Toxic epidermal necrolysis","volume":"351","author":"Becker","year":"1998","journal-title":"Lancet"},{"key":"10.1038\/sj.jid.5700648_bb0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mjd.2002.120468","article-title":"Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS","volume":"47","author":"Eliaszewicz","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/sj.jid.5700648_bb0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00128071-200001060-00003","article-title":"Drug-induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis","volume":"1","author":"Fritsch","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1038\/sj.jid.5700648_bb0035","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1084\/jem.184.2.429","article-title":"Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils","volume":"184","author":"Liles","year":"1996","journal-title":"J Exp Med"},{"key":"10.1038\/sj.jid.5700648_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11882-002-0032-z","article-title":"T cells in drug allergy","volume":"2","author":"Pichler","year":"2002","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1038\/sj.jid.5700648_bb0045","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1152\/ajpgi.2000.278.3.G354","article-title":"Fas and Fas ligand in gut and liver","volume":"278","author":"Pinkoski","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1038\/sj.jid.5700648_bb0050","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.jid.5700648_bb0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0190-9622(08)81995-0","article-title":"Toxic epidermal necrolysis: an expanding field of knowledge","volume":"31","author":"Roujeau","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/sj.jid.5700648_bb0060","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1172\/JCI119273","article-title":"Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?","volume":"99","author":"Saas","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.jid.5700648_bb0065","first-page":"123","article-title":"Toxic epidermal necrolysis","volume":"59","author":"Schwartz","year":"1997","journal-title":"Cutis"},{"key":"10.1038\/sj.jid.5700648_bb0070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nm0396-317","article-title":"Fas ligand in human serum","volume":"2","author":"Tanaka","year":"1996","journal-title":"Nat Med"},{"key":"10.1038\/sj.jid.5700648_bb0075","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1471-4906(01)02004-X","article-title":"New insights into the role of T cells in atopic dermatitis and allergic contactdermatitis","volume":"22","author":"Trautmann","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1038\/sj.jid.5700648_bb0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI9199","article-title":"T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis","volume":"106","author":"Trautmann","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.jid.5700648_bb0085","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1067\/mai.2001.118796","article-title":"Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis","volume":"108","author":"Trautmann","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/sj.jid.5700648_bb0090","doi-asserted-by":"crossref","first-page":"16183","DOI":"10.1074\/jbc.M212188200","article-title":"Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions","volume":"278","author":"Viard-Leveugle","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.jid.5700648_bb0095","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1038\/sj.jid.5700648_bb0100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008571-199508000-00011","article-title":"A slow acetylator genotype is a risk factor for sulphonamide-induced toxicepidermal necrolysis and Stevens\u2013Johnson syndrome","volume":"5","author":"Wolkenstein","year":"1995","journal-title":"Pharmacogenetics"},{"key":"10.1038\/sj.jid.5700648_bb0105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archderm.1995.01690170046006","article-title":"Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants","volume":"131","author":"Wolkenstein","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.jid.5700648_bb0110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00130832-200108000-00004","article-title":"Immunohistology of drug-induced exanthema: clues to pathogenesis","volume":"1","author":"Yawalkar","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15333480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15333480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T13:18:55Z","timestamp":1555939135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15333480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0022202X15333480"],"URL":"https:\/\/doi.org\/10.1038\/sj.jid.5700648","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1087276.540957","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}